Antiger Therapeutics
UEI: WSY4SWA56WQ7
• CAGE: 9KAS0
Overview
Awardee Type
Parent
Name
Antiger Therapeutics
Headquarters
Saint Louis, MO
United States
United States
Most Recent Award
June 20, 2024
Calculating
Federal grant recipient
ANTIGER THERAPEUTICS INC.
(UEI WSY4SWA56WQ7, CAGE 9KAS0)
is headquartered in Saint Louis MO.
The corporation
was founded in February 2022 and
federally registered in
February 2022.
Federal Award Analysis
Antiger Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ANTIGER THERAPEUTICS INC.
UEI
WSY4SWA56WQ7
CAGE Code
9KAS0
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Economically Disadvantaged Women Small Owned Business
Minority Owned Business
Woman Owned Business
Woman Owned Small Business
Economically Disadvantaged Women Small Owned Business
Minority Owned Business
Woman Owned Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Feb. 10, 2022
Initial Registration
Feb. 18, 2022
Last Registration
Sept. 5, 2024
Registration Activation
Sept. 4, 2024
Registration Expiration
Aug. 30, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MO
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
Yes